Antifungal Susceptibility Patterns, in Vitro Production of Virulence Factors, and Evaluation of Diagnostic Modalities for the Speciation of Pathogenic Candida from Blood Stream Infections and Vulvovaginal Candidiasis

Overview

Journal J Pathog

Publisher Wiley

Date 2014 Aug 12

PMID 25110589

Citations 17

Authors

Chaitanya Tellapragada

Vandana Kalwaje Eshwara

Ruqaiyah Johar

Tushar Shaw

Nidhi Malik

Parvati V Bhat

Asha Kamath

Chiranjay Mukhopadhyay

Affiliations

Soon will be listed here.

Abstract

Candida spp. have emerged as successful pathogens in both invasive and mucosal infections. Varied virulence factors and growing resistance to antifungal agents have contributed to their pathogenicity. We studied diagnostic accuracy of HiCrome Candida Differential Agar and Vitek 2 Compact system for identification of Candida spp. in comparison with species-specific PCR on 110 clinical isolates of Candida from blood stream infections (54, 49%) and vulvovaginal candidiasis (56, 51%). C. albicans (61%) was the leading pathogen in VVC, while C. tropicalis (46%) was prominent among BSIs. HiCrome Agar and Vitek 2 Compact had good measures of agreement (κ) 0.826 and 0.895, respectively, in comparison with PCR. We also tested these isolates for in vitro production of proteinase, esterase, phospholipases, and biofilms. Proteinase production was more among invasive isolates (P = 0.017), while phospholipase production was more among noninvasive isolates (P = 0.001). There was an overall increase in the production of virulence factors among non-albicans Candida. Identification of clinical isolates of Candida up to species level either by chromogenic agar or by Vitek 2 Compact system should be routinely done to choose appropriate therapy.

Citing Articles

Detection of Virulence Factors from spp. Isolated from Oral and Vaginal Candidiasis in Iraqi Patients.

Ali Hameed Al-Dabbagh A, Ali Ajah H, Abdul Sattar Salman J Arch Razi Inst. 2023; 78(1):465-474.

PMID: 37312700 PMC: 10258269. DOI: 10.22092/ARI.2022.359464.2420.

A study of the association between virulence factors and antifungal susceptibility profile of species recovered from cases of vulvovaginal candidiasis.

Siddiqui R, Mendiratta D, Siddiqui A, Rukadikar A J Family Med Prim Care. 2023; 12(1):152-159.

PMID: 37025213 PMC: 10071932. DOI: 10.4103/jfmpc.jfmpc_1479_22.

Virulence Factors of spp. and Host Immune Response Important in the Pathogenesis of Vulvovaginal Candidiasis.

Czechowicz P, Nowicka J, Gosciniak G Int J Mol Sci. 2022; 23(11).

PMID: 35682581 PMC: 9179972. DOI: 10.3390/ijms23115895.

Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination.

Frias-De-Leon M, Hernandez-Castro R, Conde-Cuevas E, Garcia-Coronel I, Vazquez-Aceituno V, Soriano-Ursua M Pharmaceutics. 2021; 13(10).

PMID: 34683822 PMC: 8538829. DOI: 10.3390/pharmaceutics13101529.

The Antimicrobial Activity of Omiganan Alone and In Combination against Isolated from Vulvovaginal Candidiasis and Bloodstream Infections.

Zyrek D, Wajda A, Czechowicz P, Nowicka J, Jaskiewicz M, Neubauer D Antibiotics (Basel). 2021; 10(8).

PMID: 34439051 PMC: 8389017. DOI: 10.3390/antibiotics10081001.

References

Tumbarello M, Posteraro B, Trecarichi E, Fiori B, Rossi M, Porta R . Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol. 2007; 45(6):1843-50. PMC: 1933062. DOI: 10.1128/JCM.00131-07. View

Williams D, Lewis M . Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011; 3. PMC: 3087208. DOI: 10.3402/jom.v3i0.5771. View

Nadeem S, Hakim S, Urooj Kazmi S . Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. Libyan J Med. 2011; 5. PMC: 3071170. DOI: 10.3402/ljm.v5i0.2144. View

Girish Kumar C, Menon T, Sundararajan T, Nalini S, Thirunarayan M, Rajasekaran S . Esterase activity of Candida species isolated from immunocompromised hosts. Rev Iberoam Micol. 2006; 23(2):101-3. View

Kumari V, Banerjee T, Kumar P, Pandey S, Tilak R . Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India. Indian J Pathol Microbiol. 2013; 56(2):144-7. DOI: 10.4103/0377-4929.118703. View

Felk A, Kretschmar M, Albrecht A, Schaller M, Beinhauer S, Nichterlein T . Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun. 2002; 70(7):3689-700. PMC: 128044. DOI: 10.1128/IAI.70.7.3689-3700.2002. View

Silva S, Hooper S, Henriques M, Oliveira R, Azeredo J, Williams D . The role of secreted aspartyl proteinases in Candida tropicalis invasion and damage of oral mucosa. Clin Microbiol Infect. 2010; 17(2):264-72. DOI: 10.1111/j.1469-0691.2010.03248.x. View

Englen M, Kelley L . A rapid DNA isolation procedure for the identification of Campylobacter jejuni by the polymerase chain reaction. Lett Appl Microbiol. 2000; 31(6):421-6. DOI: 10.1046/j.1365-2672.2000.00841.x. View

Perlroth J, Choi B, Spellberg B . Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007; 45(4):321-46. DOI: 10.1080/13693780701218689. View

10.

Zakikhany K, Naglik J, Schmidt-Westhausen A, Holland G, Schaller M, Hube B . In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell Microbiol. 2007; 9(12):2938-54. DOI: 10.1111/j.1462-5822.2007.01009.x. View

11.

Staib F . Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia. 1965; 4(3):187-93. DOI: 10.1080/00362176685190421. View

12.

Zilberberg M, Kollef M, Arnold H, Labelle A, Micek S, Kothari S . Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis. 2010; 10:150. PMC: 2890008. DOI: 10.1186/1471-2334-10-150. View

13.

Pahwa N, Kumar R, Nirkhiwale S, Bandi A . Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol. 2014; 32(1):44-8. DOI: 10.4103/0255-0857.124300. View

14.

Xess I, Jain N, Hasan F, Mandal P, Banerjee U . Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection. 2007; 35(4):256-9. DOI: 10.1007/s15010-007-6144-6. View

15.

Samaranayake Y, Dassanayake R, Jayatilake J, Cheung B, Yau J, Yeung K . Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection. J Med Microbiol. 2005; 54(Pt 6):583-593. DOI: 10.1099/jmm.0.45762-0. View

16.

Wilson D, Thewes S, Zakikhany K, Fradin C, Albrecht A, Almeida R . Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res. 2009; 9(5):688-700. DOI: 10.1111/j.1567-1364.2009.00524.x. View

17.

Chander J, Singla N, Sidhu S, Gombar S . Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India. J Infect Dev Ctries. 2013; 7(9):670-5. DOI: 10.3855/jidc.2623. View

18.

Haynes K . Virulence in Candida species. Trends Microbiol. 2001; 9(12):591-6. DOI: 10.1016/s0966-842x(01)02237-5. View

19.

De Vos M, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T . Vulvovaginal candidiasis in a Flemish patient population. Clin Microbiol Infect. 2005; 11(12):1005-11. DOI: 10.1111/j.1469-0691.2005.01281.x. View

20.

Costa C, Passos X, Souza L, Lucena P, Fernandes O, Silva M . Differences in exoenzyme production and adherence ability of Candida spp. isolates from catheter, blood and oral cavity. Rev Inst Med Trop Sao Paulo. 2010; 52(3):139-43. DOI: 10.1590/s0036-46652010000300005. View